| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |